The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: A randomised trial

Gut

Volumn 63, Issue 11, 2014, Pages 1755-1759

  Ishikawa, Hideki ^b   Mutoh, Michihiro ^a   Suzuki, Sadao ^c   Tokudome, Shinkan ^c,d   Saida, Yoshihisa ^e   Abe, Takashi ^f   Okamura, Shozo ^g   Tajika, Masahiro ^h   Joh, Takashi ^c   Tanaka, Shinji ⁱ   Kudo, Shin Ei ^j   Matsuda, Takahisa ^k   Iimuro, Masaki ^l,m   Yukawa, Tomomi ^l   Takayama, Tetsuji ⁿ   Sato, Yasushi ^o   Lee, Kyowon ^p   Kitamura, Shinji ^q   Mizuno, Motowo ^r   Sano, Yasushi ^s   Gondo, Nobuhisa ^t   Sugimoto, Kenji ^u   Kusunoki, Masato ^v   Goto, Chiho ^w   Matsuura, Nariaki ^x   Sakai, Toshiyuki ^b   Wakabayashi, Keiji ^y   more..

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^e TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^f Takarazuka City Hospital   (Japan)

^g TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^h AICHI CANCER CENTER HOSPITAL   (Japan)

ⁱ HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^j SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k NATIONAL CANCER CENTER HOSPITAL   (Japan)

^l Higashisumiyoshi Morimoto Hospital   (Japan)

^m HYOGO COLLEGE OF MEDICINE   (Japan)

ⁿ UNIVERSITY OF TOKUSHIMA   (Japan)

^o SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^p Moriguchi Keijinkai Hospital   (Japan)

^q Sakai City Medical Center   (Japan)

^r HIROSHIMA CITY HOSPITAL   (Japan)

^s NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^t Kimura Hospital   (Japan)

^u Sugimoto Clinic   (Japan)

^v MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^w NAGOYA BUNRI UNIVERSITY   (Japan)

^x OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^y UNIVERSITY OF SHIZUOKA   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; ANTINEOPLASTIC AGENT; ENTERIC COATED TABLET; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASIAN; CANCER RISK; CARCINOGENESIS; CARDIOVASCULAR DISEASE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL TUMOR; COLORECTAL TUMOURIGENESIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENTERIC COATED TABLET; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; TUMOR RECURRENCE; ADENOCARCINOMA; ADENOMA; AGED; CLINICAL TRIAL; COLONIC NEOPLASMS; DRINKING BEHAVIOR; EPIDEMIOLOGY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; ALCOHOL DRINKING; ANTICARCINOGENIC AGENTS; ASPIRIN; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS; SMOKING; TABLETS, ENTERIC-COATED;

EID: 84893158245     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305827     Document Type: Article

References (28)

1. Greving JP, Buskens E, Koffijberg H, et al. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk. Circulation 2008;117:2875-83.
2. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
3. Jacobs EJ, Thun MJ, Bain EB, et al. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 2007;99:608-15.
4. Chan AT, Arber N, Burn J, et al. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) 2012;5:164-78.
5. Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 2009;101:256-66.
6. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010;376:1741-50.
7. Ishikawa H, Wakabayashi K, Suzuki S, et al. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: Double-blind, randomized clinical trial. Cancer Med, 2013;2:50-6.
8. Farrell B, Godwin J, Richards S, et al. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044-54.
9. Uemura N, Sugano K, Hiraishi H, et al. Erratum to: Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol Published Online First: 12 Sep 2013. doi:10.1007/s00535-013-0839-5.
10. Lanza FL, Royer GL Jr, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980;303:136-8.
11. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891-9.
12. Tokudome S, Goto C, Imaeda N, et al. Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese. Asian Pacific J Cancer Prev 2004;5:40-3.
13. Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 2003;125:328-36.
14. Lanas A, Wu P, Medin J, et al. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol 2011;9:762-8.
15. Patrono C. Measurement of cyclooxygenase isozyme inhibition in humans: exploring the clinical relevance of biochemical selectivity. Clin Exp Rheumatol 2001;19: S45-50.
16. Ruffin MT, Krishnan K, Rock CL, et al. Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst 1997;89:1152-60.
17. Babbar N, Gerner EW, Casero RA Jr. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J 2006;394:317-24.
18. Martinez ME, O'Brien TG, Fultz KE, et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci USA 2003;100:7859-64.
19. Gu Q, Wang JD, Xia HH, et al. Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer. Carcinogenesis 2005;26:541-6.
20. Zimmermann KC, Waterhouse NJ, Goldstein JC, et al. Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2000;2:505-13.
21. Hawley SA, Fullerton MD, Ross FA, et al. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 2012;336:918-22.
22. Pan MR, Chang HC, Hung WC. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases. Cell Signal 2008;20:1134-41.
23. Bos CL, Kodach LL, van den Brink GR, et al. Effect of aspirin on the Wnt/ beta-catenin pathway is mediated via protein phosphatase 2A. Oncogene 2006;25:6447-56.
24. Mirkhel A, Peyster E, Sundeen J, et al. Frequency of aspirin resistance in a community hospital. Am J Cardiol 2006;98:577-9.
25. Li WJ, Zhang HY, Miao CL, et al. Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease. Chin Med J (Engl) 2011;124:1569-72.
26. Leung FW. Risk factors for gastrointestinal complications in aspirin users: review of clinical and experimental data. Dig Dis Sci 2008;53:2604-15.
27. Burn J, Bishop DT, Chapman PD, et al. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res 2011;4:655-65.
28. Pilotto A, Franceschi M, Leandro G, et al. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/ non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004;20:1091-7.